The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-0604
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2025
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Vinogradov O.I.

Pirogov National Medical and Surgical Center

Jablonskij M.A.

City polyclinic No. 4 of the Balashikha Regional Hospital

Kuznecov A.N.

Pirogov National Medical and Surgical Center

Embolic stroke of undetermined source

Authors:

Vinogradov O.I., Jablonskij M.A., Kuznecov A.N.

More about the authors

Journal: S.S. Korsakov Journal of Neurology and Psychiatry. 2020;120(12‑2): 42‑48

DOI: 10.17116/jnevro202012012242

Read: 8553 times

Download PDF (RU)
Contact the author
Table of contents

EMBOLIC STROKE OF UNDETERMINED SOURCE
EMBOLIC STROKE OF UNDETERMINED SOURCE

To cite this article:

Vinogradov OI, Jablonskij MA, Kuznecov AN. Embolic stroke of undetermined source. S.S. Korsakov Journal of Neurology and Psychiatry. 2020;120(12‑2):42‑48. (In Russ.)
https://doi.org/10.17116/jnevro202012012242

Подписка 2026 Журнал неврологии и психиатрии им. С.С. Корсакова. Спецвыпуски (S.S. Korsakov Journal of Neurology and Psychiatry (special issues))
 
МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Recommended articles:
Clinical and gene­tic asso­ciations in patients with non-cardioembolic ischemic stroke. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(12-2):12-19
Biomarkers of athe­rothrombotic and cardioembolic subtypes of acute ischemic stroke. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(12-2):20-26
Clinical and tomo­graphic comparisons in patients with apha­sia in the acute period of ischemic stroke. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(12-2):27-33
Neuroimaging predictors of hemo­rrhagic transformation of ischemic stroke. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(12-2):34-38
Neurocytoprotection adva­nces in repe­rfusion therapy. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(12-2):75-88
Improving the effe­ctiveness of treatment of patients with post-stroke apha­sia. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(10):22-28
Possibilities and limi­tations of seco­ndary prevention of chro­nic non-communicable diseases in primary care of Russia and CIS countries. Russian Journal of Preventive Medi­cine. 2024;(11):54-62
The effe­ctiveness of drug therapy in the reha­bilitation of patients with post-stroke apha­sia. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(11):132-139
Effe­ctiveness of the second stage program of medi­cal reha­bilitation of patients with ischemic heart disease. Russian Journal of Preventive Medi­cine. 2024;(12):75-80
Oxidative stress and antioxidant protection in diso­rders of cere­bral circulation. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(12):114-119
Abstract:

About 20—40% of ischemic stroke survivors cannot be attributed to a particular pathogenetic subtype despite a thorough diagnostic evaluation (cryptogenic stroke). Most cryptogenic strokes are likely embolic. This understanding is captured by a related concept, termed embolic stroke of undetermined source (ESUS), which is defined as a nonlacunar brain infarct without proximal arterial stenosis or cardioembolic sources. These patients are generally younger, has less disabilities and more favourable prognosis. It is assumed that in this group of patients, anticoagulants may have an advantage over antiplatelet drugs as a means of secondary prevention. Specific methods of treatment and secondary prevention of ESUS has not yet been developed.

Keywords:

ischemic stroke
embolic stroke of undetermined source
secondary prevention

Authors:

Vinogradov O.I.

Pirogov National Medical and Surgical Center

Jablonskij M.A.

City polyclinic No. 4 of the Balashikha Regional Hospital

Kuznecov A.N.

Pirogov National Medical and Surgical Center

Received:

03.12.2019

Accepted:

23.07.2020

Close metadata

References:

  1. Kiyuna F, Sato N, Matsuo R, Kamouchi M, Hata J, Wakisaka Y, Kuroda J, Ago T, Kitazono T, Investigators FSR. Association of Embolic Sources With Cause-Specific Functional Outcomes Among Adults With Cryptogenic Stroke. JAMA Network Open. 2018;1(5):182953-182953. https://doi.org/10.1001/jamanetworkopen.2018.2953
  2. Bembenek JP, Karlinski MA, Kurkowska-Jastrzebska I, Czlonkowska A. Embolic strokes of undetermined source in a cohort of Polish stroke patients. Neurological Sciences: Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology. 2018;39(6):1041-1047. https://doi.org/10.1007/s10072-018-3322-5
  3. Ay H, Furie KL, Singhal A, Smith WS, Sorensen AG, Koroshetz WJ. An evidence-based causative classification system for acute ischemic stroke. Annals of Neurology. 2005;58(5):688-697.  https://doi.org/10.1002/ana.20617
  4. Ay H, Benner T, Arsava EM, Furie KL, Singhal AB, Jensen MB, Ayata C, Towfighi A, Smith EE, Chong JY, Koroshetz WJ, Sorensen AG. A computerized algorithm for etiologic classification of ischemic stroke: the Causative Classification of Stroke System. Stroke. 2007;38(11):2979-2984. https://doi.org/10.1161/STROKEAHA.107.490896
  5. Hao Q, Tampi M, O’Donnell M, Foroutan F, Siemieniuk RA, Guyatt G. Clopidogrel plus aspirin versus aspirin alone for acute minor ischaemic stroke or high risk transient ischaemic attack: systematic review and meta-analysis. BMJ. 2018;363:k5108. https://doi.org/10.1136/bmj.k5108
  6. Prasad K, Siemieniuk R, Hao Q, Guyatt G, O’Donnell M, Lytvyn L, Heen AF, Agoritsas T, Vandvik PO, Gorthi SP, Fisch L, Jusufovic M, Muller J, Booth B, Horton E, Fraiz A, Siemieniuk J, Fobuzi AC, Katragunta N, Rochwerg B. Dual antiplatelet therapy with aspirin and clopidogrel for acute high risk transient ischaemic attack and minor ischaemic stroke: a clinical practice guideline. BMJ. 2018;363:k5130. https://doi.org/10.1136/bmj.k5130
  7. Hart RG, Catanese L, Perera KS, Ntaios G, Connolly SJ. Embolic stroke of undetermined source: a systematic review and clinical update. Stroke. 2017;48(4):867-872.  https://doi.org/10.1161/strokeaha.116.016414
  8. Ricci B, Chang AD. A Simple Score That Predicts Paroxysmal Atrial Fibrillation on Outpatient Cardiac Monitoring after Embolic Stroke of Unknown Source. J Stroke Cerebrovasc Dis. 2018;27(6):1692-1696. https://doi.org/10.1016/j.jstrokecerebrovasdis.2018.01.028
  9. Fan Y, Liao X, Pan Y, Dong K, Wang Y, Wang Y. Intravenous Thrombolysis Is Safe and Effective for the Cryptogenic Stroke in China: Data From the Thrombolysis Implementation and Monitor of Acute Ischemic Stroke in China (TIMS-China). Journal of Stroke and Cerebrovascular Diseases: The Official Journal of National Stroke Association. 2019;28(1):220-226.  https://doi.org/10.1016/j.jstrokecerebrovasdis.2018.09.041
  10. Gladstone DJ, Spring M, Dorian P, Panzov V, Thorpe KE, Hall J, Vaid H, O’Donnell M, Laupacis A, Côté R, Sharma M, Blakely JA, Shuaib A, Hachinski V, Coutts SB, Sahlas DJ, Teal P, Yip S, Spence JD, Buck B, Verreault S, Casaubon LK, Penn A, Selchen D, Jin A, Howse D, Mehdiratta M, Boyle K, Aviv R, Kapral MK, Mamdani M; EMBRACE Investigators and Coordinators. Atrial fibrillation in patients with cryptogenic stroke. N Engl J Med. 2014;370:2467-2477. https://doi.org/10.1056/nejmoa1311376
  11. Sanna T, Diener H-C, Passman RS, Di Lazzaro V, Bernstein RA, Morillo CA, Rymer MM, Thijs V, Rogers T, Beckers F, Lindborg K, Brachmann J. Cryptogenic Stroke and Underlying Atrial Fibrillation. New England Journal of Medicine. 2014;370(26):2478-2486. https://doi.org/10.1056/NEJMoa1313600
  12. Sebasigari D, Merkler A, Guo Y, Gialdini G, Kummer B, Hemendinger M, Song C, Chu A, Cutting S, Silver B, Elkind MSV, Kamel H, Furie KL, Yaghi S. Biomarkers of Atrial Cardiopathy and Atrial Fibrillation Detection on Mobile Outpatient Continuous Telemetry After Embolic Stroke of Undetermined Source. Journal of Stroke and Cerebrovascular Diseases: The Official Journal of National Stroke Association. 2017;26(6):1249-1253. https://doi.org/10.1016/j.jstrokecerebrovasdis.2017.01.016
  13. Bembenek JP, Karlinski MA, Kurkowska-Jastrzebska I, Czlonkowska A. Embolic strokes of undetermined source in a cohort of Polish stroke patients. Neurological Sciences: Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology. 2018;39(6):1041-1047. https://doi.org/10.1007/s10072-018-3322-5
  14. Powers WJ, Rabinstein AA, Ackerson T. 2018 Guidelines for the Early Management of Patients With Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association Originally published1 Mar 2018. https://doi.org/10.1161/STR.0000000000000158
  15. Causative Classification System for Ischemic Stroke (CCS). https://ccs.mgh.harvard.edu/ccs_intro.php
  16. Kent DM, Dahabreh IJ, Ruthazer R, Furlan AJ, Weimar C, Serena J, Meier B, Mattle HP, Di Angelantonio E, Paciaroni M, Schuchlenz H, Homma S, Lutz JS, Thaler DE. Anticoagulant vs. antiplatelet therapy in patients with cryptogenic stroke and patent foramen ovale: an individual participant data meta-analysis. Eur Heart J. 2015;36(35):2381-2389. https://doi.org/10.1093/eurheartj/ehv252
  17. Amarenco P, Albers G, Denison H, Easton D, Evans S, Held P, Hil, M, Jonasson J, Kasner S, Minematsu K, Molina C, Wang Y, Wong L, Johnston SC, Rivas R, Klapp C. Efficacy and safety of ticagrelor versus aspirin in acute stroke or transient ischaemic attack of atherosclerotic origin: a subgroup analysis of SOCRATES, a randomised, double-blind, controlled trial. The Lancet Neurology. 2017;16:301-310. 
  18. Ntaios G, Papavasileiou V, Milionis H, Makaritsis K, Vemmou A, Koroboki E, Manios E, Spengos K, Michel P, Vemmos K. Embolic strokes of undetermined source in the Athens Stroke Registry: an outcome analysis. Stroke. 2015;46(8):2087-2093. https://doi.org/10.1161/STROKEAHA.115.009334
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.